Theraclion appoints Claude Lenoir as interim chairman
Theraclion has restructured its Board of Directors, appointing Claude Lenoir as Interim Chairman after Yann Duchesne stepped down following the General Meeting on June 18, 2026. The new Board includes Lijuan Deng, Cédric Bellanger, Mehdi El Glaoui and Vincent Gardès.
*this image is generated using AI for illustrative purposes only.
Theraclion has appointed Claude Lenoir as Interim Chairman of the Board of Directors with immediate effect, following the decision by Yann Duchesne not to stand for re-election as Director and Chairman. The change in leadership was approved by shareholders during the General Meeting held on June 18, 2026. Duchesne had held these positions since January 24, 2022.
The new Board of Directors appointed by shareholders includes Ms. Lijuan Deng, Mr. Claude Lenoir, Mr. Cédric Bellanger, Mr. Mehdi El Glaoui and Mr. Vincent Gardès. Vincent Gardès joins the Board after serving as an observer in recent months. The appointment of Lenoir as Interim Chairman ensures continuity of governance pending the appointment of a permanent Chairman.
Board Composition
| Name | Role |
|---|---|
| Lijuan Deng | Director |
| Claude Lenoir | Director, Interim Chairman |
| Cédric Bellanger | Director |
| Mehdi El Glaoui | Director |
| Vincent Gardès | Director |
Martin Deterre, Chief Executive Officer of Theraclion, thanked Duchesne for his contributions to the company's strategic direction and international expansion. Deterre also expressed confidence in Lenoir's ability to lead the governance evolution.
About Theraclion
Theraclion is a MedTech company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused Ultrasound (HIFU). The technology is CE-marked under MDR (EU 2017/745) and has been used in over 4,000 procedures across more than a dozen centres worldwide. The company is listed on Euronext Growth Paris under the ticker ALTHE.
What criteria will Theraclion prioritize in the search for a permanent Chairman?
How might the new board composition influence the company's strategic direction?
What are the expected timelines for appointing a permanent Chairman?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
